Apex Biotechnology Corp. (1733)
TWSE
Closed
Oct 5, 2026
Day's Range
30.1552 wk Range
28.00Profile - 1733 - Apex Biotechnology Corp.
Profile
Mic Code
XTAI
Sector
Healthcare
Industry
Medical Devices
Employees
0
Apex Biotechnology Corp. is a leading player in the life sciences sector, primarily engaged in the research, development, and commercialization of innovative biotechnological solutions. The company focuses on creating advanced therapeutic tools and diagnostic products that address a wide array of health challenges, including metabolic, infectious, and genetic diseases. Apex Biotechnology Corp. stands out with its commitment to pioneering technologies such as CRISPR-based gene editing, personalized medicine, and cutting-edge bioinformatics. With a global reach, the company's products not only serve medical professionals and patients but also significantly impact sectors like pharmaceuticals, diagnostics, and healthcare services. Apex Biotechnology Corp. plays a crucial role in the financial market as a representative of the biotechnology industry's dynamic and high-growth potential. The company actively collaborates with research institutions and pharmaceutical giants to stay at the forefront of scientific breakthroughs, thus maintaining its market relevance and contributing to advancements in public health measures.
Profile Details
Type
Common Stock
Address
No. 7, Li-Hsin 5th Road
City
Hsinchu City
Zip
30078
Country
Taiwan
Phone
886 3 564 1952
Key Executives - 1733 - Apex Biotechnology Corp.
Key executives
Cross Listings - 1733 - Apex Biotechnology Corp.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
